Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Clinical implications of telomere dysfunction in lung fibrosis.

Molina-Molina M, Borie R.

Curr Opin Pulm Med. 2018 Sep;24(5):440-444. doi: 10.1097/MCP.0000000000000506.

PMID:
30067250
2.

The Expression of AQP1 IS Modified in Lung of Patients With Idiopathic Pulmonary Fibrosis: Addressing a Possible New Target.

Galán-Cobo A, Arellano-Orden E, Sánchez Silva R, López-Campos JL, Gutiérrez Rivera C, Gómez Izquierdo L, Suárez-Luna N, Molina-Molina M, Rodríguez Portal JA, Echevarría M.

Front Mol Biosci. 2018 May 3;5:43. doi: 10.3389/fmolb.2018.00043. eCollection 2018.

3.

Importance of early diagnosis and treatment in idiopathic pulmonary fibrosis.

Molina-Molina M, Aburto M, Acosta O, Ancochea J, Rodríguez-Portal JA, Sauleda J, Lines C, Xaubet A.

Expert Rev Respir Med. 2018 Jul;12(7):537-539. doi: 10.1080/17476348.2018.1472580. Epub 2018 May 7. No abstract available.

PMID:
29718749
4.

Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.

Molina-Molina M, Machahua-Huamani C, Vicens-Zygmunt V, Llatjós R, Escobar I, Sala-Llinas E, Luburich-Hernaiz P, Dorca J, Montes-Worboys A.

BMC Pulm Med. 2018 Apr 27;18(1):63. doi: 10.1186/s12890-018-0626-4.

5.

[Acute renal damage secondary to acute tubulointerstitial nephritis drug use. Case report].

Oikonomopoulou N, Martínez López AB, Urbano Villaescusa J, Molina Molina MDC, Butragueño Laiseca L, Barraca Nuñez D, Álvarez Blanco O.

Rev Chil Pediatr. 2017 Dec;88(6):787-791. doi: 10.4067/S0370-41062017000600787. Spanish.

6.

Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation.

Justet A, Thabut G, Manali E, Molina Molina M, Kannengiesser C, Cadranel J, Cottin V, Gondouin A, Nunes H, Magois E, Tromeur C, Prevot G, Papiris S, Marchand-Adam S, Gamez AS, Reynaud-Gaubert M, Wemeau L, Crestani B, Borie R.

Eur Respir J. 2018 Mar 15;51(3). pii: 1701875. doi: 10.1183/13993003.01875-2017. Print 2018 Mar. No abstract available.

PMID:
29449422
7.

Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?

Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, Maher TM, Molina-Molina M, Noble PW, Raghu G, Richeldi L, Schwarz MI, Selman M, Wuyts WA, Schwartz DA.

Lancet Respir Med. 2018 Feb;6(2):154-160. doi: 10.1016/S2213-2600(18)30007-9.

8.

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

Milara J, Hernandez G, Ballester B, Morell A, Roger I, Montero P, Escrivá J, Lloris JM, Molina-Molina M, Morcillo E, Cortijo J.

Respir Res. 2018 Feb 6;19(1):24. doi: 10.1186/s12931-018-0728-9.

9.

Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency.

Matamala N, Lara B, Gomez-Mariano G, Martínez S, Retana D, Fernandez T, Silvestre RA, Belmonte I, Rodriguez-Frias F, Vilar M, Sáez R, Iturbe I, Castillo S, Molina-Molina M, Texido A, Tirado-Conde G, Lopez-Campos JL, Posada M, Blanco I, Janciauskiene S, Martinez-Delgado B.

Am J Respir Cell Mol Biol. 2018 Jun;58(6):706-716. doi: 10.1165/rcmb.2017-0179OC.

PMID:
29232161
10.

Towards a global initiative for fibrosis treatment (GIFT).

Molina-Molina M, Agusti A, Crestani B, Schwartz DA, Königshoff M, Chambers RC, Maher TM, Faner R, Mora AL, Rojas M, Antoniou KM, Sellares J.

ERJ Open Res. 2017 Dec 1;3(4). pii: 00106-2017. doi: 10.1183/23120541.00106-2017. eCollection 2017 Oct.

11.

Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis.

Gabasa M, Duch P, Jorba I, Giménez A, Lugo R, Pavelescu I, Rodríguez-Pascual F, Molina-Molina M, Xaubet A, Pereda J, Alcaraz J.

Mol Biol Cell. 2017 Dec 15;28(26):3741-3755. doi: 10.1091/mbc.E17-01-0026. Epub 2017 Oct 18.

12.

Erratum to "Guidelines for the medical treatment of idiopathic pulmonary fibrosis" <[Arch Bronconeumol. 53 (2017) 263-9] >.

Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, Fernández-Fabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J.

Arch Bronconeumol. 2017 Nov;53(11):657-658. doi: 10.1016/j.arbres.2017.06.010. Epub 2017 Sep 18. English, Spanish. No abstract available.

13.

Telomere Shortening in Idiopathic Pulmonary Fibrosis.

Molina-Molina M, Planas-Cerezales L, Perona R.

Arch Bronconeumol. 2018 Jan;54(1):3-4. doi: 10.1016/j.arbres.2017.07.026. Epub 2017 Sep 14. English, Spanish. No abstract available.

14.

Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries.

Maher TM, Molina-Molina M, Russell AM, Bonella F, Jouneau S, Ripamonti E, Axmann J, Vancheri C.

BMC Pulm Med. 2017 Sep 15;17(1):124. doi: 10.1186/s12890-017-0468-5.

15.

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug.

PMID:
28860269
16.

Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain.

Mañá J, Rubio-Rivas M, Villalba N, Marcoval J, Iriarte A, Molina-Molina M, Llatjos R, García O, Martínez-Yélamos S, Vicens-Zygmunt V, Gámez C, Pujol R, Corbella X.

Medicine (Baltimore). 2017 Jul;96(29):e7595. doi: 10.1097/MD.0000000000007595.

17.

Guidelines for the medical treatment of idiopathic pulmonary fibrosis.

Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, Fernández-Fabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J.

Arch Bronconeumol. 2017 May;53(5):263-269. doi: 10.1016/j.arbres.2016.12.011. Epub 2017 Mar 11. English, Spanish. Erratum in: Arch Bronconeumol. 2017 Nov;53(11):657-658.

18.

Idiopathic pulmonary fibrosis.

Xaubet A, Ancochea J, Molina-Molina M.

Med Clin (Barc). 2017 Feb 23;148(4):170-175. doi: 10.1016/j.medcli.2016.11.004. Epub 2016 Dec 18. Review. English, Spanish.

PMID:
27998476
19.

Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.

Machahua C, Montes-Worboys A, Llatjos R, Escobar I, Dorca J, Molina-Molina M, Vicens-Zygmunt V.

Respir Res. 2016 Nov 5;17(1):144.

20.

Shrinking lung syndrome in systemic lupus erythematosus: A case series and review of the literature.

Borrell H, Narváez J, Alegre JJ, Castellví I, Mitjavila F, Aparicio M, Armengol E, Molina-Molina M, Nolla JM.

Medicine (Baltimore). 2016 Aug;95(33):e4626. doi: 10.1097/MD.0000000000004626. Review.

Supplemental Content

Loading ...
Support Center